Loading market data...
Saturday, August 22, 2026
Back to HomeKorea StockPremiumAll Hanmi Science coverage

Hanmi Science (008930.KS) Q1 2026: Net Profit Surges 73%, Ownership Battle Narrows to 5.8%

Share
Hanmi Science (008930.KS) Q1 2026: Net Profit Surges 73%, Ownership Battle Narrows to 5.8%

Hanmi Science (008930.KS) Q1 2026: Net Profit Surges 73%, Ownership Battle Narrows to 5.8%

The headline earnings jump is real but heavily distorted — remove a one-time disposal gain and underlying profit growth is closer to 20%; the genuine story is a control contest over ₩895.7 billion in equity-method investments that will determine how wide or narrow the holding company's discount to NAV remains.

Source: Quarterly Report (54th Fiscal Year, Q1) — Filed April 2026 with DART | Consolidated Financial Statements | Unit: ₩ billions

Unlimited U.S.-market analysis, $9.99/month

Hanmi Science (008930.KS) Q1 2026: Net Profit Surges 73%, Ownership Battle Narrows to 5.8%

This article became available on July 9, 2026. Subscribe to read in full, or wait until October 7, 2026 when it becomes free.

Cancel anytime. Full refund within 7 days.

Access is tied to your account. Subscribe with the same email you sign up with — if you already paid, sign up with that email and it unlocks automatically.

NewsFinanceMarkets

Go deeper than the headline

You just read what happened. Here's how to read what it means.

Free daily briefing

The U.S. market, every morning — free

LineVest Daily lands in your inbox before every opening bell: the key U.S. markets stories, earnings, disclosures and foreign flows — in plain English. Free, no card required.

Get LineVest Daily — free →
This company

Full report on Hanmi Science

We read Hanmi Science's latest SEC filing in full — financials under US GAAP, governance, and what it means for the stock. PDF in your inbox within 3 hours.

$12 · one-time

Get the Hanmi Science report
Every name you watch

Follow the whole market

Reading several U.S. stocks a week? Read every analysis article the moment it publishes — full daily U.S. market coverage plus the 90-day archive.

$9.99 · monthly

Subscribe

Independent journalism based on primary SEC filings — not investment advice. No brokerage affiliation.